What Are the Risks of Inhaled Steroid Use During Pregnancy? – Medscape

What Are the Risks of Inhaled Steroid Use During Pregnancy?
Medscape
Of these, 4083 (6.3%) of the mothers had asthma during pregnancy — a rate similar to the prevalence in the general population — and were included in the analysis. Of the women reporting lifetime asthma, 95.85% had received this diagnosis by a doctor.
Inhaled glucocorticoids during pregnancy and offspring pediatric diseasesEurekAlert (press release)
Asthma Drugs in Pregnancy Might Pose Risk for KidsU.S. News & World Report
Inhaled glucocorticoids 'not a risk factor' for most childhood diseasesInternational Federation of Gynecology and Obstetrics

all 7 news articles »

View full post on asthma – Google News

Inhaled glucocorticoids during pregnancy and offspring pediatric diseases – EurekAlert (press release)

Inhaled glucocorticoids during pregnancy and offspring pediatric diseases
EurekAlert (press release)
Inhaled glucocorticoids for the treatment of asthma during pregnancy are not associated with an increased risk of most diseases in offspring, but may be a risk factor for endocrine and metabolic disturbances, according to a new study.

and more »

View full post on asthma – Google News

Trial Looks at Strategies to Improve Inhaled Steroid Adherence and Asthma Outcomes – news Stories

Trial Looks at Strategies to Improve Inhaled Steroid Adherence and Asthma Outcomes
news Stories
Researchers recently conducted an individualized randomized controlled trial to improve inhaled steroid adherence and asthma outcomes. Their findings appear in The Journal of Allergy and Clinical Immunology. The study looked at adults with

View full post on asthma – Google News

Preterm Birth Linked to Inhaled Steroid Use in Childhood – Medscape


Moneycontrol.com

Preterm Birth Linked to Inhaled Steroid Use in Childhood
Medscape
May 10, 2011 — Preterm birth is linked to childhood use of inhaled corticosteroids (ICS; a proxy for asthma), according to the results of a Swedish national cohort study reported online May 9 and in the June print issue of Pediatrics.
Premature Babies at a Higher Asthma Risk: StudyTopNews New Zealand
Asthma risk may rise with preterm birth: studyBaltimore Sun

all 28 news articles »

View full post on asthma – Google News

Rigel Assumes Development Responsibility For Inhaled Asthma – BioResearch Online (press release)

Rigel Assumes Development Responsibility For Inhaled Asthma
BioResearch Online (press release)
South San Francisco, CA /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the company will assume development of R343, its inhaled syk inhibitor for allergic asthma that recently completed several Phase 1 clinical trials.

View full post on asthma – Google News

Rigel Assumes Development Responsibility For Inhaled Asthma Therapy – Medical News Today (press release)

Rigel Assumes Development Responsibility For Inhaled Asthma Therapy
Medical News Today (press release)
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced that the company will assume development of R343, its inhaled syk inhibitor for allergic asthma that recently completed several Phase 1 clinical trials. Pfizer Inc. is returning full rights to the

and more »

View full post on asthma – Google News